Literature DB >> 28078133

Successful hepatectomy for metastatic squamous cell carcinoma of the anal canal-a case report.

Tercia Tarciane Sousa1, Bruna do Nascimento Santos2, Marcos Belotto3, Renata D'Alpino Peixoto4.   

Abstract

Despite rare, metastatic anal carcinoma confers a poor prognosis. Systemic chemotherapy is the mainstay of treatment for advanced disease while the role of biologics and/or surgical resection of metastatic disease are anecdotal. Compared to isolated liver colorectal or neuroendocrine cancer liver metastases, there is far less experience with resection or nonsurgical local ablative procedures for patients with metastatic anal carcinoma to the liver. We report the case of a 67-year-old woman with metastatic anal carcinoma to the liver who was successfully treated with liver resection and remains free of relapse more than one year later.

Entities:  

Keywords:  Squamous cell carcinoma; metastatic anal carcinoma

Year:  2016        PMID： 28078133      PMCID： PMC5177591          DOI： 10.21037/jgo.2016.11.06

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  11 in total

1.  Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

Authors: 
Journal:  Lancet       Date:  1996-10-19       Impact factor: 79.321

Review 2.  Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem.

Authors:  J M Palefsky
Journal:  AIDS       Date:  1994-03       Impact factor: 4.177

3.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

Authors:  H Bartelink; F Roelofsen; F Eschwege; P Rougier; J F Bosset; D G Gonzalez; D Peiffert; M van Glabbeke; M Pierart
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

4.  Chemotherapy and radiation therapy for anal carcinoma. Survival and late morbidity.

Authors:  G Tanum; K Tveit; K O Karlsen; M Hauer-Jensen
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

5.  Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison.

Authors:  A Allal; J M Kurtz; G Pipard; M C Marti; R Miralbell; Y Popowski; R Egeli
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-01       Impact factor: 7.038

6.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

7.  Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.

Authors:  Karl Y Bilimoria; David J Bentrem; Colin E Rock; Andrew K Stewart; Clifford Y Ko; Amy Halverson
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

Review 8.  Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature.

Authors:  Margarita Tokar; Dmitri Bobilev; Svetlana Zalmanov; David B Geffen; Shlomo Walfisch
Journal:  Onkologie       Date:  2006-02

9.  Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

Authors:  Robert Glynne-Jones; Per J Nilsson; Carlo Aschele; Vicky Goh; Didier Peiffert; Andrés Cervantes; Dirk Arnold
Journal:  Radiother Oncol       Date:  2014-06-16       Impact factor: 6.280

10.  Surgical treatment of liver metastases in neuroendocrine neoplasms.

Authors:  Palepu Jagannath; Deepak Chhabra; Shailesh Shrikhande; Rajiv Shah
Journal:  Int J Hepatol       Date:  2012-01-26
View more
  2 in total

Review 1.  Pharmacotherapy of Anal Cancer.

Authors:  Jane E Rogers; Cathy Eng
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Stage IV anal canal squamous cell carcinoma with long-term survival: a case report.

Authors:  Katsuji Sawai; Takanori Goi; Noriyuki Tagai; Hidetaka Kurebayashi; Mitsuhiro Morikawa; Kenji Koneri; Masato Tamaki; Makoto Murakami; Yasuo Hirono; Hiroyuki Maeda
Journal:  Surg Case Rep       Date:  2022-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.